Depolarization and repolarization parameters on ECG predict recurrence after atrial fibrillation ablation in patients with hypertrophic cardiomyopathy

Introduction The outcomes of atrial fibrillation (AF) ablation remain suboptimal. It is important to identify which AF patients will most likely benefit from ablation and who are more likely to show treatment failure, especially in those with structural heart disease such as hypertrophic cardiomyopa...

Full description

Saved in:
Bibliographic Details
Published inJournal of cardiovascular electrophysiology Vol. 30; no. 11; pp. 2405 - 2413
Main Authors Wen, Song‐Nan, Zhu, Hao‐Jie, Sun, Peng‐Yu, Wu, Kui, Liu, Nian, Ruan, Yan‐Fei, Bai, Rong, Tang, Ri‐Bo, Yu, Rong‐Hui, Long, De‐Yong, Sang, Cai‐Hua, Jiang, Chen‐Xi, Li, Xin, Li, Song‐Nan, Hu, Rong, Du, Xin, Dong, Jian‐Zeng, Ma, Chang‐Sheng
Format Journal Article
LanguageEnglish
Published United States Wiley Subscription Services, Inc 01.11.2019
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Introduction The outcomes of atrial fibrillation (AF) ablation remain suboptimal. It is important to identify which AF patients will most likely benefit from ablation and who are more likely to show treatment failure, especially in those with structural heart disease such as hypertrophic cardiomyopathy (HCM). Methods and Results We enrolled 120 HCM patients who underwent primary AF ablation (48 with persistent AF). Preprocedural QTc was measured and corrected using the Bazett's formula, and the distribution of fragmentation of the QRS complex (fQRS) was recorded. Arrhythmia recurrence was defined as any kind of documented atrial tachyarrhythmia of more than 30 seconds. Overall, arrhythmia recurrence occurred in 69 patients after 13.4 months’ follow‐up. fQRS was present in 71 (59.17%) patients and was most commonly (81.69%) observed in the inferior leads. QTc more than 448 ms could predict arrhythmia recurrence with a sensitivity of 68.1% and specificity of 68.6%. Patients with QTc more than 448 ms (hazard ratio [HR]: 1.982; 95% confidence interval [CI]: 1.155‐3.402; P = .013) or those with fQRS+ (HR: 1.922; 95% CI: 1.151‐3.210; P = .012) were at an increased risk of recurrence. A combination of fQRS+ and QTc more than 448 ms was superior to fQRS or QTc alone in predicting arrhythmia recurrence. Conclusion In patients with HCM undergoing AF ablation, QTc prolongation, specifically >448 ms, and presence of fQRS are independent risk factors for arrhythmia recurrence at follow‐up. The combination of these two parameters has greater predictive value and would help to identify patients who are at the highest risk of procedural failure.
AbstractList The outcomes of atrial fibrillation (AF) ablation remain suboptimal. It is important to identify which AF patients will most likely benefit from ablation and who are more likely to show treatment failure, especially in those with structural heart disease such as hypertrophic cardiomyopathy (HCM).INTRODUCTIONThe outcomes of atrial fibrillation (AF) ablation remain suboptimal. It is important to identify which AF patients will most likely benefit from ablation and who are more likely to show treatment failure, especially in those with structural heart disease such as hypertrophic cardiomyopathy (HCM).We enrolled 120 HCM patients who underwent primary AF ablation (48 with persistent AF). Preprocedural QTc was measured and corrected using the Bazett's formula, and the distribution of fragmentation of the QRS complex (fQRS) was recorded. Arrhythmia recurrence was defined as any kind of documented atrial tachyarrhythmia of more than 30 seconds. Overall, arrhythmia recurrence occurred in 69 patients after 13.4 months' follow-up. fQRS was present in 71 (59.17%) patients and was most commonly (81.69%) observed in the inferior leads. QTc more than 448 ms could predict arrhythmia recurrence with a sensitivity of 68.1% and specificity of 68.6%. Patients with QTc more than 448 ms (hazard ratio [HR]: 1.982; 95% confidence interval [CI]: 1.155-3.402; P = .013) or those with fQRS+ (HR: 1.922; 95% CI: 1.151-3.210; P = .012) were at an increased risk of recurrence. A combination of fQRS+ and QTc more than 448 ms was superior to fQRS or QTc alone in predicting arrhythmia recurrence.METHODS AND RESULTSWe enrolled 120 HCM patients who underwent primary AF ablation (48 with persistent AF). Preprocedural QTc was measured and corrected using the Bazett's formula, and the distribution of fragmentation of the QRS complex (fQRS) was recorded. Arrhythmia recurrence was defined as any kind of documented atrial tachyarrhythmia of more than 30 seconds. Overall, arrhythmia recurrence occurred in 69 patients after 13.4 months' follow-up. fQRS was present in 71 (59.17%) patients and was most commonly (81.69%) observed in the inferior leads. QTc more than 448 ms could predict arrhythmia recurrence with a sensitivity of 68.1% and specificity of 68.6%. Patients with QTc more than 448 ms (hazard ratio [HR]: 1.982; 95% confidence interval [CI]: 1.155-3.402; P = .013) or those with fQRS+ (HR: 1.922; 95% CI: 1.151-3.210; P = .012) were at an increased risk of recurrence. A combination of fQRS+ and QTc more than 448 ms was superior to fQRS or QTc alone in predicting arrhythmia recurrence.In patients with HCM undergoing AF ablation, QTc prolongation, specifically >448 ms, and presence of fQRS are independent risk factors for arrhythmia recurrence at follow-up. The combination of these two parameters has greater predictive value and would help to identify patients who are at the highest risk of procedural failure.CONCLUSIONIn patients with HCM undergoing AF ablation, QTc prolongation, specifically >448 ms, and presence of fQRS are independent risk factors for arrhythmia recurrence at follow-up. The combination of these two parameters has greater predictive value and would help to identify patients who are at the highest risk of procedural failure.
Introduction The outcomes of atrial fibrillation (AF) ablation remain suboptimal. It is important to identify which AF patients will most likely benefit from ablation and who are more likely to show treatment failure, especially in those with structural heart disease such as hypertrophic cardiomyopathy (HCM). Methods and Results We enrolled 120 HCM patients who underwent primary AF ablation (48 with persistent AF). Preprocedural QTc was measured and corrected using the Bazett's formula, and the distribution of fragmentation of the QRS complex (fQRS) was recorded. Arrhythmia recurrence was defined as any kind of documented atrial tachyarrhythmia of more than 30 seconds. Overall, arrhythmia recurrence occurred in 69 patients after 13.4 months’ follow‐up. fQRS was present in 71 (59.17%) patients and was most commonly (81.69%) observed in the inferior leads. QTc more than 448 ms could predict arrhythmia recurrence with a sensitivity of 68.1% and specificity of 68.6%. Patients with QTc more than 448 ms (hazard ratio [HR]: 1.982; 95% confidence interval [CI]: 1.155‐3.402; P = .013) or those with fQRS+ (HR: 1.922; 95% CI: 1.151‐3.210; P = .012) were at an increased risk of recurrence. A combination of fQRS+ and QTc more than 448 ms was superior to fQRS or QTc alone in predicting arrhythmia recurrence. Conclusion In patients with HCM undergoing AF ablation, QTc prolongation, specifically >448 ms, and presence of fQRS are independent risk factors for arrhythmia recurrence at follow‐up. The combination of these two parameters has greater predictive value and would help to identify patients who are at the highest risk of procedural failure.
The outcomes of atrial fibrillation (AF) ablation remain suboptimal. It is important to identify which AF patients will most likely benefit from ablation and who are more likely to show treatment failure, especially in those with structural heart disease such as hypertrophic cardiomyopathy (HCM). We enrolled 120 HCM patients who underwent primary AF ablation (48 with persistent AF). Preprocedural QTc was measured and corrected using the Bazett's formula, and the distribution of fragmentation of the QRS complex (fQRS) was recorded. Arrhythmia recurrence was defined as any kind of documented atrial tachyarrhythmia of more than 30 seconds. Overall, arrhythmia recurrence occurred in 69 patients after 13.4 months' follow-up. fQRS was present in 71 (59.17%) patients and was most commonly (81.69%) observed in the inferior leads. QTc more than 448 ms could predict arrhythmia recurrence with a sensitivity of 68.1% and specificity of 68.6%. Patients with QTc more than 448 ms (hazard ratio [HR]: 1.982; 95% confidence interval [CI]: 1.155-3.402; P = .013) or those with fQRS+ (HR: 1.922; 95% CI: 1.151-3.210; P = .012) were at an increased risk of recurrence. A combination of fQRS+ and QTc more than 448 ms was superior to fQRS or QTc alone in predicting arrhythmia recurrence. In patients with HCM undergoing AF ablation, QTc prolongation, specifically >448 ms, and presence of fQRS are independent risk factors for arrhythmia recurrence at follow-up. The combination of these two parameters has greater predictive value and would help to identify patients who are at the highest risk of procedural failure.
IntroductionThe outcomes of atrial fibrillation (AF) ablation remain suboptimal. It is important to identify which AF patients will most likely benefit from ablation and who are more likely to show treatment failure, especially in those with structural heart disease such as hypertrophic cardiomyopathy (HCM).Methods and ResultsWe enrolled 120 HCM patients who underwent primary AF ablation (48 with persistent AF). Preprocedural QTc was measured and corrected using the Bazett's formula, and the distribution of fragmentation of the QRS complex (fQRS) was recorded. Arrhythmia recurrence was defined as any kind of documented atrial tachyarrhythmia of more than 30 seconds. Overall, arrhythmia recurrence occurred in 69 patients after 13.4 months’ follow‐up. fQRS was present in 71 (59.17%) patients and was most commonly (81.69%) observed in the inferior leads. QTc more than 448 ms could predict arrhythmia recurrence with a sensitivity of 68.1% and specificity of 68.6%. Patients with QTc more than 448 ms (hazard ratio [HR]: 1.982; 95% confidence interval [CI]: 1.155‐3.402; P = .013) or those with fQRS+ (HR: 1.922; 95% CI: 1.151‐3.210; P = .012) were at an increased risk of recurrence. A combination of fQRS+ and QTc more than 448 ms was superior to fQRS or QTc alone in predicting arrhythmia recurrence.ConclusionIn patients with HCM undergoing AF ablation, QTc prolongation, specifically >448 ms, and presence of fQRS are independent risk factors for arrhythmia recurrence at follow‐up. The combination of these two parameters has greater predictive value and would help to identify patients who are at the highest risk of procedural failure.
Author Ma, Chang‐Sheng
Ruan, Yan‐Fei
Sun, Peng‐Yu
Yu, Rong‐Hui
Wen, Song‐Nan
Wu, Kui
Long, De‐Yong
Li, Xin
Bai, Rong
Li, Song‐Nan
Jiang, Chen‐Xi
Du, Xin
Tang, Ri‐Bo
Liu, Nian
Dong, Jian‐Zeng
Hu, Rong
Zhu, Hao‐Jie
Sang, Cai‐Hua
Author_xml – sequence: 1
  givenname: Song‐Nan
  surname: Wen
  fullname: Wen, Song‐Nan
  organization: Capital Medical University
– sequence: 2
  givenname: Hao‐Jie
  surname: Zhu
  fullname: Zhu, Hao‐Jie
  organization: Capital Medical University
– sequence: 3
  givenname: Peng‐Yu
  surname: Sun
  fullname: Sun, Peng‐Yu
  organization: Capital Medical University
– sequence: 4
  givenname: Kui
  surname: Wu
  fullname: Wu, Kui
  organization: Capital Medical University
– sequence: 5
  givenname: Nian
  orcidid: 0000-0002-3324-8606
  surname: Liu
  fullname: Liu, Nian
  organization: Capital Medical University
– sequence: 6
  givenname: Yan‐Fei
  surname: Ruan
  fullname: Ruan, Yan‐Fei
  organization: Capital Medical University
– sequence: 7
  givenname: Rong
  orcidid: 0000-0002-3106-7318
  surname: Bai
  fullname: Bai, Rong
  organization: Capital Medical University
– sequence: 8
  givenname: Ri‐Bo
  surname: Tang
  fullname: Tang, Ri‐Bo
  organization: Capital Medical University
– sequence: 9
  givenname: Rong‐Hui
  surname: Yu
  fullname: Yu, Rong‐Hui
  organization: Capital Medical University
– sequence: 10
  givenname: De‐Yong
  orcidid: 0000-0003-4604-5346
  surname: Long
  fullname: Long, De‐Yong
  organization: Capital Medical University
– sequence: 11
  givenname: Cai‐Hua
  surname: Sang
  fullname: Sang, Cai‐Hua
  organization: Capital Medical University
– sequence: 12
  givenname: Chen‐Xi
  surname: Jiang
  fullname: Jiang, Chen‐Xi
  organization: Capital Medical University
– sequence: 13
  givenname: Xin
  surname: Li
  fullname: Li, Xin
  organization: Capital Medical University
– sequence: 14
  givenname: Song‐Nan
  surname: Li
  fullname: Li, Song‐Nan
  organization: Capital Medical University
– sequence: 15
  givenname: Rong
  surname: Hu
  fullname: Hu, Rong
  organization: Capital Medical University
– sequence: 16
  givenname: Xin
  surname: Du
  fullname: Du, Xin
  organization: Capital Medical University
– sequence: 17
  givenname: Jian‐Zeng
  orcidid: 0000-0001-7299-7805
  surname: Dong
  fullname: Dong, Jian‐Zeng
  organization: Capital Medical University
– sequence: 18
  givenname: Chang‐Sheng
  orcidid: 0000-0001-6966-6239
  surname: Ma
  fullname: Ma, Chang‐Sheng
  email: chshma@vip.sina.com
  organization: Capital Medical University
BackLink https://www.ncbi.nlm.nih.gov/pubmed/31441155$$D View this record in MEDLINE/PubMed
BookMark eNp1kc9u1DAQxi1URP_AgRdAlrjAIa0ndpzdI1q2BVSJC5wtx5lovUriMHZULQ_C89btpgcqmMuMrd_3aTTfOTsZw4iMvQVxCbmu9g4vQYGsX7AzqJQoVqDrkzwLVRVyVctTdh7jXgiQWlSv2KkEpQCq6oz9-YxT6C353zb5MHI7tpz-_pos2QETUuT5td3c8Imw9S5l0M1EODrktssAt4m87XnnG_J9vzg2y-AfrJLHMUV-59OO7w4TUqIw7bzjzlLrw3AImdkdXrOXne0jvln6Bft5vf2x-VLcfr_5uvl0WzhZybooS620FViVjegapaRupVbooNYtqLWtoXVat67TTWMBZOuwU0rYbo1OlR3IC_bh6DtR-DVjTGbw0WHefcQwR1OWKwkgKl1m9P0zdB9mGvN2ppRiXWtY6SpT7xZqbgZszUR-sHQwTxfPwNURcBRiJOyM8-nxQIms7w0I85CpyZmax0yz4uMzxZPpv9jF_c73ePg_aL5ttkfFPQ49s40
CitedBy_id crossref_primary_10_3390_jcm14030809
crossref_primary_10_1016_j_cdtm_2020_05_006
crossref_primary_10_1016_j_hjc_2022_05_002
crossref_primary_10_1016_j_cjca_2024_01_026
crossref_primary_10_3389_fcvm_2024_1483591
crossref_primary_10_1016_j_cpcardiol_2022_101524
Cites_doi 10.1161/CIRCULATIONAHA.105.595892
10.1001/jama.2014.3
10.1016/j.eupc.2005.05.015
10.1016/S0008-6363(02)00258-4
10.1097/RLI.0000000000000326
10.1046/j.1540-8167.2004.03625.x
10.1016/j.jacc.2013.03.032
10.1016/j.jacc.2011.06.011
10.1016/j.jacc.2007.09.026
10.1016/S0735-1097(01)01727-2
10.1253/circj.CJ-14-0822
10.1093/europace/euv067
10.1111/j.1540-8167.2006.00621.x
10.1016/0735-1097(90)90180-W
10.1161/CIR.0b013e318223e2bd
10.1161/CIRCULATIONAHA.108.770917
10.1016/j.jacc.2012.03.076
10.1253/circj.CJ-14-1290
10.12669/pjms.304.5064
10.1016/j.joa.2016.10.005
10.1111/pace.13292
10.1093/europace/euq013
10.1111/jce.12629
ContentType Journal Article
Copyright 2019 Wiley Periodicals, Inc.
Copyright_xml – notice: 2019 Wiley Periodicals, Inc.
DBID AAYXX
CITATION
NPM
7QP
K9.
7X8
DOI 10.1111/jce.14137
DatabaseName CrossRef
PubMed
Calcium & Calcified Tissue Abstracts
ProQuest Health & Medical Complete (Alumni)
MEDLINE - Academic
DatabaseTitle CrossRef
PubMed
ProQuest Health & Medical Complete (Alumni)
Calcium & Calcified Tissue Abstracts
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic

PubMed
ProQuest Health & Medical Complete (Alumni)
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Anatomy & Physiology
Biology
EISSN 1540-8167
EndPage 2413
ExternalDocumentID 31441155
10_1111_jce_14137
JCE14137
Genre article
Journal Article
GrantInformation_xml – fundername: National Key Research and Development Program of China
  funderid: 2016YFC0900901; 2016YFC1201703; 2016YFC1301002; 2017YFC0908803; 2018YFC1312501
– fundername: Natural ScienceFoundation of Beijing Municipality
  funderid: 7161003
– fundername: Excellent Talent of Beijing
  funderid: 2015000021469G195
– fundername: National Natural Science Foundation of China
  funderid: 2015000021469G195
– fundername: Beijing Municipal Science & Technology Commission
  funderid: Z181100001718105
– fundername: Capital Health Research and Development of Special
  funderid: 2016‐2‐2062
– fundername: Natural ScienceFoundation of Beijing Municipality
  grantid: 7161003
– fundername: Capital Health Research and Development of Special
  grantid: 2016-2-2062
– fundername: National Key Research and Development Program of China
  grantid: 2016YFC0900901
– fundername: Beijing Municipal Science & Technology Commission
  grantid: Z181100001718105
– fundername: National Key Research and Development Program of China
  grantid: 2016YFC1301002
– fundername: National Key Research and Development Program of China
  grantid: 2017YFC0908803
– fundername: National Key Research and Development Program of China
  grantid: 2018YFC1312501
– fundername: Excellent Talent of Beijing
  grantid: 2015000021469G195
– fundername: National Natural Science Foundation of China
  grantid: 2015000021469G195
– fundername: National Key Research and Development Program of China
  grantid: 2016YFC1201703
GroupedDBID ---
.3N
.GA
.GJ
.Y3
04C
05W
0R~
10A
1OB
1OC
29K
31~
33P
36B
3SF
4.4
50Y
50Z
51W
51X
52M
52N
52O
52P
52R
52S
52T
52U
52V
52W
52X
53G
5GY
5HH
5LA
5RE
5VS
66C
6PF
702
7PT
8-0
8-1
8-3
8-4
8-5
8UM
930
A01
A03
AAESR
AAEVG
AAHHS
AAHQN
AAIPD
AAMNL
AANHP
AANLZ
AAONW
AASGY
AAWTL
AAXRX
AAYCA
AAZKR
ABCQN
ABCUV
ABDBF
ABEML
ABJNI
ABPVW
ABQWH
ABXGK
ACAHQ
ACBWZ
ACCFJ
ACCZN
ACGFO
ACGFS
ACGOF
ACIWK
ACMXC
ACPOU
ACPRK
ACRPL
ACSCC
ACUHS
ACXBN
ACXQS
ACYXJ
ADBBV
ADBTR
ADEOM
ADIZJ
ADKYN
ADMGS
ADNMO
ADOJX
ADOZA
ADXAS
ADZMN
ADZOD
AEEZP
AEGXH
AEIGN
AEIMD
AENEX
AEQDE
AEUQT
AEUYR
AFBPY
AFEBI
AFFPM
AFGKR
AFPWT
AFRAH
AFWVQ
AFZJQ
AHBTC
AHEFC
AHMBA
AIACR
AIAGR
AITYG
AIURR
AIWBW
AJBDE
ALAGY
ALMA_UNASSIGNED_HOLDINGS
ALUQN
ALVPJ
AMBMR
AMYDB
ATUGU
AZBYB
AZFZN
AZVAB
BAFTC
BDRZF
BFHJK
BHBCM
BMSDO
BMXJE
BPMNR
BROTX
BRXPI
BY8
C45
CAG
COF
CS3
D-6
D-7
D-E
D-F
D-I
DC6
DCZOG
DPXWK
DR2
DRFUL
DRMAN
DRSTM
DU5
EAD
EAP
EAS
EBC
EBD
EBS
ECF
ECT
ECV
EIHBH
EJD
EMB
EMK
EMOBN
ENC
EPT
ESX
EX3
F00
F01
F04
F5P
FEDTE
FUBAC
FZ0
G-S
G.N
GODZA
H.X
HF~
HGLYW
HVGLF
HZI
HZ~
IHE
IX1
J0M
K48
KBYEO
LATKE
LC2
LC3
LEEKS
LH4
LITHE
LOXES
LP6
LP7
LUTES
LW6
LYRES
MEWTI
MK4
MRFUL
MRMAN
MRSTM
MSFUL
MSMAN
MSSTM
MXFUL
MXMAN
MXSTM
N04
N05
N9A
NF~
O66
O9-
OIG
OVD
P2P
P2W
P2X
P2Z
P4B
P4D
PALCI
PQQKQ
Q.N
Q11
QB0
Q~Q
R.K
RIWAO
ROL
RX1
SAMSI
SUPJJ
SV3
TEORI
TUS
UB1
V8K
VVN
W8V
W99
WBKPD
WHWMO
WIH
WIJ
WIK
WOHZO
WOW
WQ9
WQJ
WRC
WUP
WVDHM
WXI
WXSBR
XG1
ZGI
ZXP
ZZTAW
~IA
~WT
AAYXX
ACDOS
AEYWJ
AGHNM
AGQPQ
AGYGG
CITATION
NPM
7QP
AAMMB
AEFGJ
AGXDD
AIDQK
AIDYY
K9.
7X8
ID FETCH-LOGICAL-c3537-22646a0e52b0fb4436d364ec176d149a71dc66dcf6bba113dcef440af9ec42f13
IEDL.DBID DR2
ISSN 1045-3873
1540-8167
IngestDate Thu Jul 10 23:21:41 EDT 2025
Fri Jul 25 20:03:05 EDT 2025
Wed Feb 19 02:31:32 EST 2025
Thu Apr 24 23:06:17 EDT 2025
Tue Jul 01 01:54:08 EDT 2025
Wed Jan 22 16:37:59 EST 2025
IsPeerReviewed true
IsScholarly true
Issue 11
Keywords QTc interval
atrial fibrillation
catheter ablation
hypertrophic cardiomyopathy
fragmented QRS
Language English
License 2019 Wiley Periodicals, Inc.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c3537-22646a0e52b0fb4436d364ec176d149a71dc66dcf6bba113dcef440af9ec42f13
Notes Part of results of this study has been accepted for an abstract presentation in 2017 Annual Session of European Society of Cardiology (Barcelona, Spain).
Disclosure
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
ORCID 0000-0001-6966-6239
0000-0001-7299-7805
0000-0003-4604-5346
0000-0002-3106-7318
0000-0002-3324-8606
PMID 31441155
PQID 2309761865
PQPubID 1086397
PageCount 9
ParticipantIDs proquest_miscellaneous_2283110562
proquest_journals_2309761865
pubmed_primary_31441155
crossref_citationtrail_10_1111_jce_14137
crossref_primary_10_1111_jce_14137
wiley_primary_10_1111_jce_14137_JCE14137
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate November 2019
2019-11-00
2019-Nov
20191101
PublicationDateYYYYMMDD 2019-11-01
PublicationDate_xml – month: 11
  year: 2019
  text: November 2019
PublicationDecade 2010
PublicationPlace United States
PublicationPlace_xml – name: United States
– name: Hoboken
PublicationTitle Journal of cardiovascular electrophysiology
PublicationTitleAlternate J Cardiovasc Electrophysiol
PublicationYear 2019
Publisher Wiley Subscription Services, Inc
Publisher_xml – name: Wiley Subscription Services, Inc
References e_1_2_7_1_11_1
e_1_2_7_1_12_1
e_1_2_7_1_13_1
Çetin M (e_1_2_7_1_10_1) 2012; 12
Patel SI (e_1_2_7_1_18_1) 2018; 7
e_1_2_7_1_5_1
e_1_2_7_1_6_1
e_1_2_7_1_7_1
e_1_2_7_1_8_1
e_1_2_7_1_25_1
e_1_2_7_1_2_1
e_1_2_7_1_26_1
e_1_2_7_1_3_1
e_1_2_7_1_4_1
e_1_2_7_1_21_1
e_1_2_7_1_22_1
e_1_2_7_1_23_1
e_1_2_7_1_24_1
e_1_2_7_1_9_1
e_1_2_7_1_20_1
e_1_2_7_1_19_1
e_1_2_7_1_14_1
e_1_2_7_1_15_1
e_1_2_7_1_16_1
e_1_2_7_1_17_1
References_xml – ident: e_1_2_7_1_7_1
  doi: 10.1161/CIRCULATIONAHA.105.595892
– ident: e_1_2_7_1_23_1
  doi: 10.1001/jama.2014.3
– ident: e_1_2_7_1_5_1
  doi: 10.1016/j.eupc.2005.05.015
– ident: e_1_2_7_1_26_1
  doi: 10.1016/S0008-6363(02)00258-4
– ident: e_1_2_7_1_24_1
  doi: 10.1097/RLI.0000000000000326
– volume: 12
  start-page: 576
  year: 2012
  ident: e_1_2_7_1_10_1
  article-title: Fragmented QRS may predict postoperative atrial fibrillation in patients undergoing isolated coronary artery bypass graft surgery
  publication-title: Anadolu Kardiyol Derg
– ident: e_1_2_7_1_14_1
  doi: 10.1046/j.1540-8167.2004.03625.x
– volume: 7
  start-page: 1
  year: 2018
  ident: e_1_2_7_1_18_1
  article-title: QT prolongation and sudden cardiac death risk in hypertrophic cardiomyopathy
  publication-title: Acta Cardiol
– ident: e_1_2_7_1_11_1
  doi: 10.1016/j.jacc.2013.03.032
– ident: e_1_2_7_1_13_1
  doi: 10.1016/j.jacc.2011.06.011
– ident: e_1_2_7_1_25_1
  doi: 10.1016/j.jacc.2007.09.026
– ident: e_1_2_7_1_3_1
  doi: 10.1016/S0735-1097(01)01727-2
– ident: e_1_2_7_1_20_1
  doi: 10.1253/circj.CJ-14-0822
– ident: e_1_2_7_1_16_1
  doi: 10.1093/europace/euv067
– ident: e_1_2_7_1_15_1
  doi: 10.1111/j.1540-8167.2006.00621.x
– ident: e_1_2_7_1_2_1
  doi: 10.1016/0735-1097(90)90180-W
– ident: e_1_2_7_1_4_1
  doi: 10.1161/CIR.0b013e318223e2bd
– ident: e_1_2_7_1_8_1
  doi: 10.1161/CIRCULATIONAHA.108.770917
– ident: e_1_2_7_1_21_1
  doi: 10.1016/j.jacc.2012.03.076
– ident: e_1_2_7_1_12_1
  doi: 10.1253/circj.CJ-14-1290
– ident: e_1_2_7_1_19_1
  doi: 10.12669/pjms.304.5064
– ident: e_1_2_7_1_22_1
  doi: 10.1016/j.joa.2016.10.005
– ident: e_1_2_7_1_17_1
  doi: 10.1111/pace.13292
– ident: e_1_2_7_1_6_1
  doi: 10.1093/europace/euq013
– ident: e_1_2_7_1_9_1
  doi: 10.1111/jce.12629
SSID ssj0013605
Score 2.3268507
Snippet Introduction The outcomes of atrial fibrillation (AF) ablation remain suboptimal. It is important to identify which AF patients will most likely benefit from...
The outcomes of atrial fibrillation (AF) ablation remain suboptimal. It is important to identify which AF patients will most likely benefit from ablation and...
IntroductionThe outcomes of atrial fibrillation (AF) ablation remain suboptimal. It is important to identify which AF patients will most likely benefit from...
SourceID proquest
pubmed
crossref
wiley
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 2405
SubjectTerms Arrhythmia
atrial fibrillation
Cardiac arrhythmia
Cardiomyopathy
catheter ablation
Coronary artery disease
Depolarization
EKG
Electrocardiography
Fibrillation
fragmented QRS
Health risk assessment
Heart diseases
hypertrophic cardiomyopathy
QTc interval
Risk factors
Tachyarrhythmia
Title Depolarization and repolarization parameters on ECG predict recurrence after atrial fibrillation ablation in patients with hypertrophic cardiomyopathy
URI https://onlinelibrary.wiley.com/doi/abs/10.1111%2Fjce.14137
https://www.ncbi.nlm.nih.gov/pubmed/31441155
https://www.proquest.com/docview/2309761865
https://www.proquest.com/docview/2283110562
Volume 30
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lj9MwELZWi0BceOzyKCwrgxDiklUcO04jTm23ZbXSckCstAekyJ7Y2hVtWqXpofwQfi9jxwmUh4S4Ock4D3km_sae-YaQ1wJ4BsLwSCSl22bMZKRBsmhYGoETFgyZL9p38UGeXYrzq_Rqj7zrcmFafoh-wc1Zhv9fOwNXev2zkYNBM2fcZZK7WC0HiD4mP3YQ2pxI9DZSxx_LA6uQj-Lpeu7ORb8BzF286iec2X3yuXvVNs7ky8mm0Sfw9RcWx__8lgfkXgCidNRqzkOyZ6oDcjiq0AlfbOkb6kND_Zr7Abk97lp3LsJe_CH5dorYHf3ikMhJVVXSeveU4xVfuHibNcWj6eQ9XdWuf4OC4ImhwFBfpZwqXz6EWpeBMJ-HO-rQuHG38vyva-oWjuk1es91Uy9X1zdAwYfULrZLV115-4hczqafJmdRqPIQAU95FrlMXqlikyY6tloILksuhQFUmxLdN5WxEqQswUqtFWO8BGOFiJXNDYjEMv6Y7FfLyjwlNGNJEttUKMZRouR5DAlIq20urFAiH5C33XgXECjQXSWOedG7QmAKPxAD8qoXXbW8H38SOuqUpgimvy7Qp0OIx4YyHZCX_WU0WrcToyqz3KAMgjrEXYg9B-RJq2z9U7hzcRHl4ct6lfn744vzydQ3nv276HNyFyFf3mZTHpH9pt6YFwirGn1Mbo3Gp-PZsbej72R2IPM
linkProvider Wiley-Blackwell
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V1Lc9MwEN4pZXhceLQ8AgUEAx0u7liWLMcHDiVJSR_pgWlnejO2LE07JHbGcYYxP4RfwV_hP7GSHxAeM1x64KYkG1kj70rfSrvfArzkkgWSK-ZwLzXXjIFwEimo008Vxw1L9qkt2jc5FuNTfnDmn63B1zYXpuaH6A7cjGXY9doYuDmQ_tnKpUI7pyxoQioPVfUJHbbFm_0hvt1Xnrc3OhmMnaamgCOZzwLH5I2K2FW-l7g64ZyJlAmuJA4yRWchDmgqhUilFkkSU8pSqTTnbqxDJbmnKcN-r8BVU0HcMPUP33s_7izqLEz0b3zDWMsaHiMbN9QOdXX3-w3SriJku8Xt3YZv7eTUkS0fd5ZlsiM__8Ib-b_M3h241WBtslsbx11YU9kGbO5mcZnPKrJNbPSrvVbYgGtv29b1SRNusAlfhuieoOvf5KqSOEtJsfqVoU6fmZCiBcFPo8E7Mi_M_0sUlJb7SipiC7GT2FZIIdokWUynTY9J07gwXVmK2wUxZ-PkvJqroizy-fmFJNJGDc-q3BSQru7B6aVM231Yz_JMPQQSUM9ztc9jylAiZaErPSl0okOueczDHrxuFSySDcu7KTYyjTpvT6rIvvgevOhE5zW1yZ-EtlotjZrVbRGh24oolvaF34Pn3c-4LpnLpjhT-RJlELcitER43YMHtXZ3T2HGi0cgi4O1Ovr3x0cHg5FtPPp30WdwY3wyOYqO9o8PH8NNRLhhnTy6BetlsVRPEEWWyVNrvAQ-XLa-fwcE9n4s
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V1Lb9QwEB6VIiouPFoeCwUMAsQlVRI7zubAoeyDPmiFEJV6C4kfasVuEmWzQuGH8Cf4K_woxs4DlofEpQduzmbWsZwZ-5t45huAp0zQUDBFHeZLc8wYcicV3HOGUjHcsMTQs0X7jo753gk7OA1O1-BrlwvT8EP0H9yMZdj12hh4IfXPRi4UmrlHwzai8lDVn9BfW7zcH-PLfeb708n70Z7TlhRwBA1o6Ji0UZ64KvBTV6eMUS4pZ0rgGCX6CknoScG5FJqnaeJ5VAqlGXMTHSnBfO1R7PcSXGbcjUydiPE7_8eRRZOEie5NYAhraUtjZMOGuqGubn6_IdpVgGx3uOl1-NbNTRPY8nFnWaU74vMvtJH_yeTdgGst0ia7jWnchDWVbcLWbpZU-bwmz4mNfbWHCptw5VXX2jhqgw224MsYnRN0_NtMVZJkkpSrPxni9LkJKFoQvJqMXpOiNP-vUFBY5iuhiC3DThJbH4Vok2Ixm7U9pm3j3HRlCW4XxHwZJ2d1ocqqzIuzc0GEjRme17kpH13fgpMLmbbbsJ7lmboLJPR839UBSzyKEpJGrvAF16mOmGYJiwbwotOvWLQc76bUyCzufT2hYvviB_CkFy0aYpM_CW13Shq3a9siRqcVMaw35MEAHve3cVUyR01JpvIlyiBqRWCJ4HoAdxrl7p9CjQ-PMBYHa1X074-PD0YT27j376KPYOPteBq_2T8-vA9XEd5GTeboNqxX5VI9QAhZpQ-t6RL4cNHq_h0CSXzb
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Depolarization+and+repolarization+parameters+on+ECG+predict+recurrence+after+atrial+fibrillation+ablation+in+patients+with+hypertrophic+cardiomyopathy&rft.jtitle=Journal+of+cardiovascular+electrophysiology&rft.au=Wen%2C+Song-Nan&rft.au=Zhu%2C+Hao-Jie&rft.au=Sun%2C+Peng-Yu&rft.au=Wu%2C+Kui&rft.date=2019-11-01&rft.eissn=1540-8167&rft.volume=30&rft.issue=11&rft.spage=2405&rft_id=info:doi/10.1111%2Fjce.14137&rft_id=info%3Apmid%2F31441155&rft.externalDocID=31441155
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1045-3873&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1045-3873&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1045-3873&client=summon